As XOM prepares to release its Q1 2026 earnings on May 1, the timing aligns with volatile oil prices and escalating geopolitical tensions in the Middle East. In my view, the integrated oil major has capitalized on robust upstream performance and disciplined cost management, contributing to shares climbing nearly 30% year-to-date on the back of sustained energy demand. Refining margins have softened, however, and planned maintenance along with regional disruptions present headwinds. This report stands out for investors like me who are monitoring the company's path to record production targets in basins such as the Permian and Guyana, while assessing the strength of downstream operations. Broader dynamics—including OPEC+ decisions and global supply chains—further elevate its relevance for positioning in the energy sector.
Wall Street expects Q1 EPS of $1.01 on revenue of $85.29 billion, marking lower profitability compared to Q1 2025's $1.76 EPS and $83.13 billion in sales, according to 19 analysts. The Zacks Consensus is in line at $1.07 EPS.
From the company's April 8 outlook relative to Q4 2025, upstream earnings could increase by $1.1-$2.9 billion, driven by higher liquids prices ($1.9-$2.3B) and gas prices, though offset by Middle East volume impacts (-$0.5-$0.3B) and downtime. Energy Products anticipates a $4.2-$4.6 billion headwind from timing effects and maintenance (-$0.6-$0.4B). Chemical margins are projected to decline by $0.4-$0.2 billion. Overall, EPS should come in higher than Q4 excluding identified timing items, which are expected to reverse later in the year.
One thing that stands out are the key metrics: Permian output targeting over 20% growth, Guyana ramp-up, post-maintenance refining utilization, and free cash flow generation. XOM has a track record of frequently beating EPS estimates, though stock reactions have been mixed. I also checked peers using Tickeron’s AI Screener to contextualize these figures.
Sentiment heading into earnings feels balanced to me—optimism around upstream drivers tempered by caution on refining pressures and disruptions. XOM shares have benefited from crude price recovery, but history indicates post-earnings downside in 75% of the last 12 quarters. Implied volatility points to a potential 4-5% move. On the risk side, weaker volumes or downward guidance revisions could weigh on the stock; conversely, production beats might drive upside.
In my own research process, I frequently use Tickeron’s AI Screener, an AI-powered stock and ETF discovery tool that filters the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of stocks and ETFs with customizable criteria like industry, market cap, technical indicators, price patterns, and performance metrics, helping me pinpoint trade ideas, trending names, breakouts, and opportunities more efficiently than manual screening. If you're looking to streamline your stock analysis, it's a practical addition to the toolkit.
I'll be paying close attention to Q1 guidance on full-year 2026, particularly any reaffirmation of $27-29 billion in cash capex directed toward high-return projects. XOM aims for structural earnings growth via Permian expansion—targeting over 1 million barrels per day oil equivalent—and the Guyana Payara Phase 2 startup, which should add low-cost barrels.
Refining margins continue to face oversupply pressures, while chemicals depend on economic rebound. Upstream production reached records last year; Q2 maintenance effects and OPEC+ supply cues will be in focus. Shareholder returns persist through $4-5 billion in quarterly buybacks, backed by a solid balance sheet.
Longer term, I'm watching low-emission investments and carbon capture advancements amid energy transition shifts. Key catalysts ahead include Q2 results and initial Guyana cargoes.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where XOM advanced for three days, in 232 of 371 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 192 of 312 cases where XOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The 10-day RSI Indicator for XOM moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 24 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 66 cases where XOM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XOM as a result. In 48 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 52%.
The Moving Average Convergence Divergence Histogram (MACD) for XOM turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 24 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 47%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
XOM broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 27, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 10 (best 1 - 100 worst), indicating outstanding price growth. XOM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XOM's P/B Ratio (2.848) is slightly higher than the industry average of (1.641). XOM has a moderately high P/E Ratio (23.124) as compared to the industry average of (10.995). Projected Growth (PEG Ratio) (1.392) is also within normal values, averaging (1.088). Dividend Yield (0.023) settles around the average of (0.050) among similar stocks. P/S Ratio (1.911) is also within normal values, averaging (3.764).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a distributer of crude oil, natural gas and petroleum products
Industry IntegratedOil